1. Home
  2. PHAR vs WGO Comparison

PHAR vs WGO Comparison

Compare PHAR & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.44

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Winnebago Industries Inc.

WGO

Winnebago Industries Inc.

HOLD

Current Price

$40.08

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAR
WGO
Founded
1988
1958
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PHAR
WGO
Price
$16.44
$40.08
Analyst Decision
Strong Buy
Buy
Analyst Count
3
12
Target Price
$30.00
$40.00
AVG Volume (30 Days)
21.0K
491.5K
Earning Date
11-06-2025
12-19-2025
Dividend Yield
N/A
3.57%
EPS Growth
N/A
106.82
EPS
0.00
0.91
Revenue
$362,274,000.00
$2,798,200,000.00
Revenue This Year
$24.80
$3.24
Revenue Next Year
$6.84
$5.40
P/E Ratio
$3,084.39
$43.12
Revenue Growth
26.78
N/A
52 Week Low
$7.50
$28.00
52 Week High
$18.12
$57.55

Technical Indicators

Market Signals
Indicator
PHAR
WGO
Relative Strength Index (RSI) 49.79 63.51
Support Level $15.76 $39.14
Resistance Level $18.12 $41.32
Average True Range (ATR) 0.83 1.58
MACD -0.12 0.27
Stochastic Oscillator 28.81 77.52

Price Performance

Historical Comparison
PHAR
WGO

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.

Share on Social Networks: